Rogers (ROG) swings to 2025 loss but Q4 improves and 2026 outlook rises

Rhea-AI Filing Summary

Rogers Corporation reported mixed results for 2025, with net sales of $810.8 million, slightly below 2024’s $830.1 million, and a full-year net loss of $61.8 million, or $(3.40) per share, driven largely by $97.1 million of restructuring, severance, impairment and related costs.

On an adjusted basis, 2025 earnings were $2.39 per diluted share versus $2.72 in 2024, and adjusted EBITDA was $115.0 million versus $118.7 million. Fourth quarter trends were stronger: Q4 2025 net sales rose to $201.5 million, up 4.8% year over year, with GAAP EPS of $0.26 versus a $(0.03) loss and adjusted EPS of $0.89 versus $0.46.

Q4 adjusted EBITDA increased to $34.4 million, and adjusted EBITDA margin improved to 17.1%. Operating cash flow for 2025 was $101.2 million and free cash flow was $71.1 million, while year-end cash and cash equivalents reached $197.0 million after $14.3 million of share repurchases in Q4. For Q1 2026, the company guides to net sales of $193–$208 million, gross margin of 30.5%–32.5%, adjusted EPS of $0.45–$0.85 and adjusted EBITDA of $27–$35 million, with planned 2026 capital expenditures of $30–$40 million.

Positive

• None.

Negative

• Full-year swing to GAAP loss driven by large restructuring: 2025 GAAP net loss was $61.8 million, or $(3.40) per share, versus 2024 net income of $26.1 million, mainly reflecting $97.1 million of restructuring, severance, impairment and related costs.

Insights

Equity analyst

Heavy 2025 restructuring costs drove a GAAP loss, but Q4 profitability, margins and cash flow improved and guidance points to modest early-2026 growth.

Rogers Corporation posted 2025 net sales of $810.8 million, slightly below 2024, and a GAAP net loss of $61.8 million as restructuring, severance, impairment and related costs totaled $97.1 million. This contrasts with 2024 net income of $26.1 million.

Underlying performance was steadier. Adjusted EBITDA was $115.0 million versus $118.7 million in 2024, and adjusted earnings per diluted share were $2.39 versus $2.72. Q4 2025 net sales of $201.5 million grew 4.8% year over year, while adjusted EPS nearly doubled to $0.89, supported by higher sales and lower operating expenses.

Liquidity appears solid, with year-end cash of $197.0 million, 2025 operating cash flow of $101.2 million and free cash flow of $71.1 million, even after Q4 share repurchases of $14.3 million. For Q1 2026, guidance implies roughly 5% sales growth at the midpoint, 160 basis points of gross margin improvement and a 530 basis point increase in adjusted EBITDA margin versus Q1 2025, indicating management’s expectation of better profitability as restructuring benefits flow through.

0000084748false00000847482026-02-172026-02-17

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): February 17, 2026

ROGERS CORPORATION

(Exact name of registrant as specified in its charter)

Massachusetts

1-4347

06-0513860

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

2225 W. Chandler Blvd., Chandler, Arizona 85224

(Address of principal executive offices) (Zip Code)

(480) 917-6000

Registrant’s telephone number, including area code

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐			Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 Securities registered pursuant to Section 12(b) of the Act:

Title of each class						Trading Symbol(s)			Name of each exchange on which registered
Common Stock,			par value $1.00 per share			ROG			New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

Item 7.01 Regulation FD Disclosure.

In a press release dated February 17, 2026, Rogers Corporation (the “Company”) announced its fourth quarter and fiscal year 2025 results. A copy of that press release is furnished herewith as Exhibit 99.1 and incorporated herein to these Items 2.02 and 7.01 by reference.

All information in this Form 8-K and the Exhibits attached hereto, including guidance or any other forward-looking statements, speaks as of February 17, 2026, and the Company undertakes no duty to update this information to reflect subsequent events, actual results or changes in the Company’s expectations, unless required by law.

The information in Items 2.02 and 7.01 of this Form 8-K and the Exhibits attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

			Exhibit No.			Description
			99.1			Press release issued by Rogers Corporation on February 17, 2026.
			104			Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ROGERS CORPORATION

(Registrant)

Date: February 17, 2026

By:

/s/ Laura Russell

Laura Russell

Senior Vice President, Chief Financial Officer and Treasurer Principal Financial Officer

Rogers Corporation Reports Fourth Quarter and Full Year 2025 Results

•Net sales of $810.8 million in 2025 and $201.5 million for the fourth quarter

•Gross margin of 31.7% in 2025 and 31.5% for the fourth quarter

•Net income (loss) of $(61.8) million in 2025 and $4.6 million for the fourth quarter

•Adjusted EBITDA of $115.0 million in 2025 and $34.4 million for the fourth quarter

•Loss per share of $(3.40) in 2025 and earnings per share of $0.26 for the fourth quarter

•Adjusted earnings per share of $2.39 in 2025 and $0.89 for the fourth quarter

Chandler, Arizona, February 17, 2025: Rogers Corporation (NYSE:ROG) today announced financial results for the full year and fourth quarter of 2025.

"Solid execution led to sales, gross margin and adjusted earnings per share that approached or exceeded the high-end of guidance for the fourth quarter,” stated Ali El-Haj, Rogers' Interim President and CEO. "We are encouraged that the benefits of cost improvement initiatives implemented in recent quarters are contributing to significantly higher adjusted earnings per share compared with the same period last year.”

"Rogers enters 2026 in a strong position with a streamlined operating structure, an enhanced innovation strategy, and a healthy balance sheet which we expect will enable a return to growth and meaningfully improved results for shareholders."

Financial Overview

GAAP Results (dollars in millions, except per share amounts)			Q4 2025			Q3 2025			Q4 2024			2025			2024
Net Sales			$201.5			$216.0			$192.2			$810.8			$830.1
Gross Margin			31.5%			33.5%			32.1%			31.7%			33.4%
Net Income (Loss)			$4.6			$8.6			$(0.5)			$(61.8)			$26.1
Diluted Earnings (Loss) Per Share			$0.26			$0.48			$(0.03)			$(3.40)			$1.40
Adjusted Earnings Per Diluted Share1			$0.89			$0.90			$0.46			$2.39			$2.72
Adjusted EBITDA1			$34.4			$37.2			$23.3			$115.0			$118.7
Net Cash Provided by Operating Activities			$46.9			$28.9			$33.7			$101.2			$127.1
Free Cash Flow1			$42.2			$21.2			$18.3			$71.1			$71.0

1 - Adjusted Earnings Per Diluted Share, Adjusted EBITDA and Free Cash Flow are non-GAAP measures. A reconciliation of non-GAAP to GAAP

measures is provided in the schedules included below.

Q4 2025 Summary of Results

Net sales of $201.5 million increased 4.8% versus the prior year quarter primarily from higher industrial, ADAS and renewable energy sales. Currency exchange rates favorably affected total Company net sales in the fourth quarter of 2025 by $3.7 million compared to the fourth quarter of 2024.

GAAP earnings per diluted share were $0.26 compared to a loss per share of $(0.03) in Q4 2024. On an adjusted basis, earnings were $0.89 per diluted share compared to earnings of $0.46 per diluted share in the prior year quarter. The improvement in adjusted earnings resulted from higher sales and lower operating expenses.

Fourth quarter ending cash and cash equivalents were $197.0 million, an increase of $29.2 million compared to the prior quarter. Net cash provided by operating activities was $46.9 million and increased by $18.0 million due to lower inventories and other working capital improvements. Share repurchases totaled $14.3 million and capital expenditures were $4.7 million.

1

Financial Outlook

At the mid-point of the guidance for the first quarter of 2026 the Company expects 5% sales growth, a 160 basis point improvement in gross margin and a 530 basis point increase in adjusted EBITDA margin, compared to Q1 2025.

(dollars in millions, except per share amounts)			Q1 2026
Net Sales			$193 to $208
Gross Margin			30.5% to 32.5%
Adjusted Earnings Per Diluted Share			$0.45 to $0.85
Adjusted EBITDA			$27 to $35
			2026
Capital Expenditures			$30 to $40

Conference Call and Additional Information

A conference call to discuss the results for the fourth quarter and full year will take place today, Tuesday, February 17, 2026 at 5:00 pm ET. A live webcast of the event and the accompanying presentation can be accessed on the Rogers Corporation website at https://www.rogerscorp.com/investors.

About Rogers Corporation

Rogers Corporation (NYSE:ROG) is a global leader in engineered materials to power, protect and connect our world. Rogers delivers innovative solutions to help our customers solve their toughest material challenges. Rogers’ advanced electronic and elastomeric materials are used in applications for EV/HEV, automotive safety and radar systems, mobile devices, renewable energy, wireless infrastructure, energy-efficient motor drives, industrial equipment and more. Headquartered in Chandler, Arizona, Rogers operates manufacturing facilities in the United States (U.S.), Asia and Europe, with sales offices worldwide.

2

Safe Harbor Statement

Statements included in this release that are not a description of historical facts are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements are generally accompanied by words or phrases such as “anticipate,” “assume,” “believe,” “could,” “estimate,” “expect,” “foresee,” “goal,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “should,” “seek,” “target” or similar expressions that convey uncertainty as to the future events or outcomes. Forward-looking statements are based on assumptions and beliefs that we believe to be reasonable; however, assumed facts almost always vary from actual results, and the differences between assumed facts and actual results could be material depending upon the circumstances. Where we express an expectation or belief as to future results, that expectation or belief is expressed in good faith and based on assumptions believed to have a reasonable basis. We cannot assure you, however, that the stated expectation or belief will occur or be achieved or accomplished. This release contains forward-looking statements regarding our plans, objectives, outlook, goals, strategies, future events, future net sales or performance, capital expenditures, future restructuring, plans or intentions relating to expansions, business trends and other information that is not historical information. All forward-looking statements are based upon information available to us on the date of this release and are subject to risks, uncertainties and other factors, many of which are outside of our control, which could cause actual results to differ materially from those indicated by the forward-looking statements. Other risks and uncertainties that could cause such results to differ include the following, without limitation: failure to capitalize on, volatility within, or other adverse changes with respect to growth opportunities, such as delays in adoption or implementation of new technologies; uncertain business, economic and political conditions in the U.S. and abroad, particularly in China, Germany, England, Belgium, South Korea and Hungary, where we maintain significant manufacturing, sales or administrative operations; the global trade policy dynamics between nations reflected in trade agreement negotiations, imposition of tariffs and other trade restrictions, as well as the potential for global supply chain decoupling; fluctuations in foreign currency exchange rates; our ability to develop innovative products and the extent to which they are incorporated into end-user products and systems that achieve commercial success; the ability and willingness of our sole or limited source suppliers to deliver certain key raw materials, including commodities, to us in a timely and cost-effective manner; business interruptions due to catastrophes or other similar events, such as natural disasters, war, terrorism or public health crises; the impact of sanctions, export controls and other foreign asset or investment restrictions; failure to realize, or delays in the realization of anticipated benefits of acquisitions and divestitures due to, among other things, the existence of unknown liabilities or difficulty integrating acquired businesses; our ability to attract and retain management and skilled technical personnel; our ability to protect our proprietary technology from infringement by third parties and/or allegations that our technology infringes third party rights; changes in effective tax rates or tax laws and regulations in the jurisdictions in which we operate; failure to comply with financial and restrictive covenants in our credit agreement or restrictions on our operational and financial flexibility due to such covenants; the outcome of ongoing and future litigation, including our asbestos-related product liability litigation; changes in environmental laws and regulations applicable to our business; and disruptions in, or breaches of, our information technology systems. Should any risks and uncertainties develop into actual events, these developments could have a material adverse effect on the Company. Our forward-looking statements are expressly qualified by these cautionary statements, which you should consider carefully. For additional information about the risks, uncertainties and other factors that may affect our business, please see our most recent annual report on Form 10-K and any subsequent reports filed with the Securities and Exchange Commission, including quarterly reports on Form 10-Q. Rogers Corporation assumes no responsibility to update or revise any forward-looking statements contained herein, whether as a result of new information, future events or otherwise, except as required by law.

Investor Contact:

Steve Haymore

Phone: 480-917-6026

Email: stephen.haymore@rogerscorporation.com

Website Address: https://www.rogerscorp.com

(Financial statements follow)

3

Condensed Consolidated Statements of Operations (Unaudited)

(DOLLARS AND SHARES IN MILLIONS, EXCEPT PER SHARE AMOUNTS)

			Three Months Ended												Twelve Months Ended
			December 31, 2025						December 31, 2024						December 31, 2025						December 31, 2024
Net sales			$	201.5					$	192.2					$	810.8					$	830.1
Cost of sales			138.0						130.5						554.0						553.0
Gross margin			63.5						61.7						256.8						277.1
Selling, general and administrative expenses			42.0						49.9						176.6						193.4
Research and development expenses			6.6						8.1						28.1						34.6
Restructuring and impairment charges			8.0						16.3						97.1						24.1
Other operating (income) expense, net			(0.2)						0.1						—						0.1
Operating income (loss)			7.1						(12.7)						(45.0)						24.9
Equity income in unconsolidated joint ventures			—						0.2						—						1.4
Other income (expense), net			2.5						9.6						(0.9)						8.8
Interest income (expense), net			(0.1)						0.2						0.8						(0.8)
Income (loss) before income taxes			9.5						(2.7)						(45.1)						34.3
Income tax (benefit) expense			4.9						(2.2)						16.7						8.2
Net income (loss)			$	4.6					$	(0.5)					$	(61.8)					$	26.1
Basic earnings (loss) per share			$	0.26					$	(0.03)					$	(3.40)					$	1.40
Diluted earnings (loss) per share			$	0.26					$	(0.03)					$	(3.40)					$	1.40
Shares used in computing:
Basic earnings (loss) per share			17.9						18.6						18.2						18.6
Diluted earnings (loss) per share			18.0						18.6						18.2						18.6

4

Condensed Consolidated Statements of Financial Position (Unaudited)

(DOLLARS AND SHARES IN MILLIONS, EXCEPT PAR VALUE)			December 31, 2025						December 31, 2024
Assets
Current assets
Cash and cash equivalents			$	197.0					$	159.8
Accounts receivable, net			130.6						135.3
Contract assets			27.9						23.7
Inventories, net			125.0						142.3
Asbestos-related insurance recoverables, current portion			4.7						4.3
Other current assets			14.8						28.5
Total current assets			500.0						493.9
Property, plant and equipment, net of accumulated depreciation			372.4						365.1
Operating lease right-of-use assets			19.2						24.1
Goodwill			303.4						357.6
Intangible assets, net of accumulated amortization			99.3						110.3
Asbestos-related insurance recoverables, non-current portion			48.1						48.0
Deferred income taxes			67.0						61.5
Other long-term assets			20.5						20.6
Total assets			$	1,429.9					$	1,481.1
Liabilities and Shareholders’ Equity
Current liabilities
Accounts payable			$	42.9					$	48.1
Accrued employee benefits and compensation			43.2						41.5
Accrued income taxes payable			10.2						7.7
Operating lease obligations, current portion			3.9						4.0
Asbestos-related liabilities, current portion			5.5						5.4
Other accrued liabilities			20.4						16.8
Total current liabilities			126.1						123.5
Operating lease obligations, non-current portion			17.9						20.6
Asbestos-related liabilities, non-current portion			51.9						52.1
Non-current income tax			4.8						5.7
Deferred income taxes			17.7						18.0
Other long-term liabilities			15.8						9.6
Shareholders’ equity
Capital stock - $1 par value; 50.0 authorized shares; 17.8 and 18.5 shares issued and outstanding, respectively			17.8						18.5
Additional paid-in capital			105.7						147.3
Retained earnings			1,119.3						1,181.1
Accumulated other comprehensive loss			(47.1)						(95.3)
Total shareholders' equity			1,195.7						1,251.6
Total liabilities and shareholders' equity			$	1,429.9					$	1,481.1

5

Reconciliation of non-GAAP financial measures to the comparable GAAP measures

Non-GAAP Financial Measures:

This earnings release includes the following financial measures that are not presented in accordance with generally accepted accounting principles in the United States of America (“GAAP”):

(1) Adjusted earnings per diluted share, which the Company defines as earnings (loss) per diluted share excluding acquisition and related integration costs, dispositions, intangible amortization, (gains) losses on the sale or disposal of property, plant and equipment, restructuring, severance, impairment and other related costs, asbestos-related charges (credits), and the related income tax effect on these items, and charges to income tax expense for valuation allowances on deferred tax assets generated in prior years, divided by adjusted weighted average shares outstanding - diluted;

(2) Adjusted EBITDA, which the Company defines as net income (loss) excluding acquisition and related integration costs, dispositions, intangible amortization, (gains) losses on the sale or disposal of property, plant and equipment, restructuring, severance, impairment and other related costs, asbestos-related charges (credits), interest income (expense), net, income tax (benefit) expense , depreciation of fixed assets, and equity compensation expense;

(3) Adjusted EBITDA Margin, which the Company defines as the percentage that results from dividing Adjusted EBITDA by total net sales;

(4) Free cash flow, which the Company defines as net cash provided by operating activities less non-acquisition capital expenditures.

Management believes adjusted earnings per diluted share, adjusted EBITDA and adjusted EBITDA margin are useful to investors because they allow for comparison to the Company’s performance in prior periods without the effect of items that, by their nature, tend to obscure the Company’s core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. As a result, management believes that these measures enhance the ability of investors to analyze trends in the Company’s business and evaluate the Company’s performance relative to peer companies. Management also believes free cash flow is useful to investors as an additional way of viewing the Company's liquidity and provides a more complete understanding of factors and trends affecting the Company's cash flows. However, non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation from, or as alternatives to, financial measures prepared in accordance with GAAP. In addition, these non-GAAP financial measures may differ from, and should not be compared to, similarly named measures used by other companies. Reconciliations of the differences between these non-GAAP financial measures and their most directly comparable financial measures calculated in accordance with GAAP are set forth below.

The Company provides first quarter 2026 guidance for adjusted earnings per diluted share and adjusted EBITDA on a non-GAAP basis only. The forward-looking comparable GAAP measures and a reconciliation of adjusted earnings per share and adjusted EBITDA to GAAP are excluded in reliance upon the exception provided by Item 10(e)(1)(i)(B) of Regulation S-K due to the inherent difficulty in forecasting and quantifying, without unreasonable efforts, certain reconciling items. These include, among other things, adjustments that could be made for acquisition and related integration costs, dispositions, intangible amortization, (gains) losses on the sale or disposal of property, plant and equipment, restructuring, severance, impairment and other related costs, asbestos-related charges (credits), and charges to income tax expense for valuation allowances on deferred tax assets generated in prior years, and other charges reflected in the Company’s reconciliations of historic numbers, the amount of which, based on historical experience, could be significant.

6

Reconciliation of GAAP Earnings (Loss) Per Diluted Share to Adjusted Earnings Per Diluted Share*:

			2025									2024
			Q4			Q3			YTD			Q4			YTD
GAAP Earnings (Loss) Per Diluted Share			$	0.26		$	0.48		$	(3.40)		$	(0.03)		$	1.40
Acquisition & Divestiture Related Costs:
Acquisition & Related Integration Costs			—			—			—			(0.40)			(0.40)
Intangible Amortization			0.16			0.15			0.60			0.17			0.67
(Gain) Loss on Sale or Disposal of PPE			—			—			—			0.01			0.01
Restructuring, Business Realignment & Other Cost Saving Initiatives:
Restructuring, Severance, Impairment & Other Related Costs			0.44			0.39			5.34			0.91			1.51
Asbestos-Related Charges (Credits)			—			—			—			0.08			0.08
Valuation Allowances against Deferred Tax Assets			(0.05)			—			0.16			—			—
Estimated Income Tax Impacts of Adjustments			0.09			(0.13)			(0.31)			(0.27)			(0.54)
Impact of Including Dilutive Securities			—			—			—			—			—
Total Adjustments			$	0.64		$	0.41		$	5.78		$	0.49		$	1.31
Adjusted Earnings Per Diluted Share			$	0.89		$	0.90		$	2.39		$	0.46		$	2.72

*Values in table may not add due to rounding.

The following table reconciles weighted average shares outstanding - diluted under US GAAP to adjusted weighted average shares outstanding - diluted used in the calculation of adjusted diluted EPS:

			2025									2024
(shares in millions)			Q4			Q3			YTD			Q4			YTD
Weighed average shares outstanding - diluted			18.0			18.1			18.2			18.6			18.6
Dilutive effect of awards under equity compensation plans			—			—			—			—			—
Adjusted weighted average shares outstanding - diluted			18.0			18.1			18.2			18.6			18.6

7

Reconciliation of GAAP Net Income (Loss) to Adjusted EBITDA*:

			2025									2024
(dollars in millions)			Q4			Q3			YTD			Q4			YTD
GAAP Net Income (Loss)			$	4.6		$	8.6		$	(61.8)		$	(0.5)		$	26.1
Acquisition & Divestiture Related Costs:
Acquisition & Related Integration Costs			—			—			—			(7.5)			(7.5)
Dispositions			—			—			—			—			—
Intangible Amortization			2.8			2.8			11.0			3.1			12.4
(Gain) Loss on Sale or Disposal of PPE			—			—			—			0.1			0.1
Restructuring, Business Realignment & Other Cost Saving Initiatives:
Restructuring, Severance, Impairment & Other Related Costs			8.0			7.1			97.1			16.9			28.0
Asbestos-Related Charges (Credits)			—			—			—			1.4			1.4
Interest (Income) Expense, net			0.1			(0.2)			(0.8)			(0.2)			0.8
Income Tax (Benefit) Expense			4.9			7.7			16.7			(2.2)			8.2
Depreciation			11.8			10.4			41.9			9.3			34.1
Equity Compensation			2.2			0.8			10.9			2.9			15.1
Total Adjustments			$	29.8		$	28.6		$	176.8		$	23.8		$	92.6
Adjusted EBITDA			$	34.4		$	37.2		$	115.0		$	23.3		$	118.7

*Values in table may not add due to rounding.

Calculation of Adjusted EBITDA margin*:

			2025									2024
(dollars in millions)			Q4			Q3			YTD			Q4			YTD
Adjusted EBITDA			$	34.4		$	37.2		$	115.0		$	23.3		$	118.7
Divided by Total Net Sales			201.5			216.0			810.8			192.2			830.1
Adjusted EBITDA Margin			17.1		%	17.2		%	14.2		%	12.1		%	14.3		%

*Values in table may not add due to rounding.

Reconciliation of Net Cash Provided By Operating Activities to Free Cash Flow:

			2025									2024
(dollars in millions)			Q4			Q3			YTD			Q4			YTD
Net Cash Provided By Operating Activities			$	46.9		$	28.9		$	101.2		$	33.7		$	127.1
Non-Acquisition Capital Expenditures			(4.7)			(7.7)			(30.1)			(15.4)			(56.1)
Free Cash Flow			$	42.2		$	21.2		$	71.1		$	18.3		$	71.0

# # # #

8

FAQ

How did Rogers Corporation (ROG) perform financially in 2025?

Rogers Corporation reported 2025 net sales of $810.8 million, slightly below $830.1 million in 2024, and a GAAP net loss of $61.8 million, or $(3.40) per share, mainly due to $97.1 million of restructuring and related charges.

What were Rogers Corporation (ROG) fourth quarter 2025 results?

In Q4 2025, Rogers generated net sales of $201.5 million, up 4.8% year over year, with GAAP diluted EPS of $0.26 versus a $(0.03) loss in Q4 2024 and adjusted diluted EPS of $0.89 versus $0.46, reflecting higher sales and lower operating expenses.

How did Rogers Corporation (ROG) 2025 adjusted metrics compare to 2024?

Adjusted earnings per diluted share for 2025 were $2.39, down from $2.72 in 2024, while adjusted EBITDA was $115.0 million versus $118.7 million. Adjusted EBITDA margin was 14.2% in 2025, essentially in line with 14.3% in 2024.

What is Rogers Corporation (ROG) guidance for Q1 2026?

For Q1 2026, Rogers expects net sales of $193–$208 million, gross margin of 30.5%–32.5%, adjusted earnings per diluted share of $0.45–$0.85, and adjusted EBITDA of $27–$35 million, implying about 5% sales growth at the midpoint versus Q1 2025.

What was Rogers Corporation (ROG) 2025 cash flow and year-end cash position?

In 2025, Rogers generated net cash from operating activities of $101.2 million and free cash flow of $71.1 million. Year-end cash and cash equivalents were $197.0 million, up from $159.8 million, after funding $30.1 million of non-acquisition capital expenditures and $14.3 million of Q4 share repurchases.

How did restructuring and impairment charges affect Rogers Corporation (ROG) in 2025?

Rogers recorded $97.1 million of restructuring, severance, impairment and other related costs in 2025, sharply higher than $28.0 million in 2024. These charges were a key driver of the shift from 2024 net income of $26.1 million to a 2025 net loss of $61.8 million.

Filing Exhibits & Attachments

4 documents

Press Releases

• EX-99.1 EX-99.1 256.3 KB

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 1.7 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 21.4 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT 12.2 KB